Trial intelligence / Profile preview

Sodium nitrite and isoquercetin in chronic kidney disease

NCT02552888Phase 2Completed

Sponsor
Tulane University
Start
Mar 2016
Primary completion
Jun 2017
Modality
Small Molecules
Countries
1
01

Overview

A Phase 2 trial of sodium nitrite, isoquercetin in chronic kidney disease (CKD), sponsored by Tulane University. Started Mar 2016; status: completed.

02

Drugs

sodium nitriteisoquercetin
03

Conditions

chronic kidney disease (CKD)

Beyond the preview

Go deeper on NCT02552888.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT02552888.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call